Similarly, using the same mouse model, another study demonstrated that moderate PERK activation promotes remyelinating oligodendrocyte survival and remyelination in demyelinated lesions in models of MS (Lin et al., 2014a). Here, EIF2AK3 is linked to myeloid sarcoma.